id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-D-0038-0005,FDA,FDA-1998-D-0038,Tina Wimbush,Other,LET-Letter,2003-11-14T05:00:00Z,2003,11,,,2008-05-16T21:22:42Z,,0,0,090000648056e1ed
FDA-1998-D-0038-0006,FDA,FDA-1998-D-0038,Tina Wimbush,Other,LET-Letter,2003-11-14T05:00:00Z,2003,11,,,2008-05-16T21:18:50Z,,0,0,090000648056e1ee
FDA-1998-D-0038-0004,FDA,FDA-1998-D-0038,FDA,Notice,NAD-Notice of Availability of Data,2003-10-28T05:00:00Z,2003,10,2003-10-27T05:00:00Z,,2008-05-16T21:22:42Z,,0,0,090000648056e1e4
FDA-1998-D-0038-0003,FDA,FDA-1998-D-0038,Guidance,Supporting & Related Material,GDL-Guidance,2003-10-28T05:00:00Z,2003,10,,,2008-05-16T21:22:08Z,,0,0,090000648056e1e3
FDA-1998-D-0038-0002,FDA,FDA-1998-D-0038,FDA,Notice,N-Notice,2003-09-29T04:00:00Z,2003,9,2003-09-19T04:00:00Z,,2008-05-16T21:21:03Z,,0,0,090000648056e1dc